After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Gilead Sciences Inc (GILD) stock saw a modest uptick, ending the day at $91 which represents a slight increase of $1.06 or 1.18% from the prior close of $89.94. The stock opened at $90.59 and touched ...

Stephen King has a slew of new books coming out in the next few years, but long-teased sequel he finally confirmed is the ...

Explore book-based TV series on DVD and streaming at Manistee County Library, including "Longmire" and "Shogun." ...

The colorful picture book is helping parents of young children deal with the difficult journey that follows a breast cancer ...

Gilead Sciences Inc (GILD) stock saw a modest uptick, ending the day at $89.88 which represents a slight increase of $0.74 or 0.83% from the prior close of $89.14. The stock opened at $90.19 and ...

The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and other national leaders have published an online book, "Advancing the Science of Cancer in Latinos: 2024 ...

the Royalty Agreement, under which Galapagos will gain full global development and commercialization rights to its pipeline, subject to payment of single digit royalties to Gilead on net sales of ...

Nurix Therapeutics (NRIX) leads in targeted protein modulation with its DELigase platform, developing BTK degraders like ...